BAX Stock Overview
Through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Baxter International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$32.87 |
| 52 Week High | US$44.01 |
| 52 Week Low | US$31.60 |
| Beta | 0.60 |
| 11 Month Change | -8.62% |
| 3 Month Change | -13.09% |
| 1 Year Change | -9.55% |
| 33 Year Change | -55.92% |
| 5 Year Change | -59.42% |
| Change since IPO | 2,411.86% |
Recent News & Updates
Recent updates
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?
Sep 05
Baxter- Reiterating Our Buy Rating After A Promising Q2
Aug 07Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29
Aug 07Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
Jul 23Baxter: Why Investors Should Take Advantage Of The Low Valuation
Jul 16Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues
Jul 12Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 30Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
May 14Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff
May 08Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal
Apr 14Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
Feb 23Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Feb 20Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden
Jan 28Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital
Jan 12Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares
Dec 28Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield
Dec 12Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)
Nov 27Is Baxter International (NYSE:BAX) A Risky Investment?
Oct 27Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
Oct 12There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital
Sep 21Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
Aug 23Dividend Challengers Review: Baxter International
Aug 14Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
Jul 25Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet
Jul 14Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
Jun 12Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture
Jun 07Baxter International's (NYSE:BAX) Dividend Will Be $0.29
May 19Shareholder Returns
| BAX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.1% | 1.2% | 2.0% |
| 1Y | -9.5% | 22.6% | 32.4% |
Return vs Industry: BAX underperformed the US Medical Equipment industry which returned 21.9% over the past year.
Return vs Market: BAX underperformed the US Market which returned 32.6% over the past year.
Price Volatility
| BAX volatility | |
|---|---|
| BAX Average Weekly Movement | 3.5% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BAX has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BAX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1931 | 60,000 | Joe Almeida | www.baxter.com |
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Baxter International Inc. Fundamentals Summary
| BAX fundamental statistics | |
|---|---|
| Market cap | US$17.06b |
| Earnings (TTM) | US$121.00m |
| Revenue (TTM) | US$15.06b |
138.7x
P/E Ratio1.1x
P/S RatioIs BAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BAX income statement (TTM) | |
|---|---|
| Revenue | US$15.06b |
| Cost of Revenue | US$9.42b |
| Gross Profit | US$5.64b |
| Other Expenses | US$5.52b |
| Earnings | US$121.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 37.47% |
| Net Profit Margin | 0.80% |
| Debt/Equity Ratio | 162.9% |
How did BAX perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield487%
Payout RatioDoes BAX pay a reliable dividends?
See BAX dividend history and benchmarks| Baxter International dividend dates | |
|---|---|
| Ex Dividend Date | Nov 29 2024 |
| Dividend Pay Date | Jan 02 2025 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 35 days |
Does BAX pay a reliable dividends?
See BAX dividend history and benchmarks